Baseline characteristics of participants in the Hypertension in the Very Elderly Trial (HYVET)

Autor:	Christopher J. Bulpitt, Jan A. Staessen, D Dumitrascu, Winston Banya, Ruth Peters, Vassil Stoyanovsky, Yuri Nikitin, Lisheng Liu, Ji-Guang Wang, N Beckett, Astrid E. Fletcher, Lisa Burch
Jazyk:	angličtina
Rok vydání:	2009
Předmět:	Blood Glucose Male medicine.medical_specialty Alcohol Drinking Blood sugar Comorbidity Placebo Hemoglobins chemistry.chemical_compound Diabetes mellitus Internal medicine Internal Medicine Perindopril medicine Humans Urea Aged Randomized Controlled Trials as Topic Aged 80 and over Creatinine Anthropometry business.industry Patient Selection Cholesterol HDL Smoking Indapamide General Medicine medicine.disease Lipids Uric Acid Endocrinology Blood pressure Hematocrit chemistry Hypertension Female Metabolic syndrome Cardiology and Cardiovascular Medicine business medicine.drug
Popis:	The Hypertension in the Very Elderly Trial (HYVET) is a randomized double-blind trial of active antihypertensive treatment (indapamide 1.5 mg sustained release +/-2-4 mg perindopril) vs placebo in participants over the age of 80 years with a systolic blood pressure (SBP) of 160-199 mmHg during a placebo run-in period plus a diastolic blood pressure (DBP) of
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7f94a50d0bac6754cd1bef177fd5f35 https://lirias.kuleuven.be/handle/123456789/259798 Zobrazit plný text záznamu